Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to IMVT. [ FAQ on what and how to ask] For non-IMVT questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 1000 Park Forty Plaza, Suite 210, Durham, NC, United States, 27713
Employees: 315
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Executive Chairperson of the Board
CEO & Director
Chief Financial Officer
Chief Operating Officer
Chief Technology Officer
Chief Legal Officer & Corporate Secretary
Senior Vice President of Human Resources
Senior VP & Global Head of Quality
Senior Vice President of Biostatistics, Programming & Data Management
Senior Vice President of Clinical Development
My Watchlist
